PMGC Holdings Inc. (NASDAQ:ELAB) Short Interest Update

PMGC Holdings Inc. (NASDAQ:ELAB) was the recipient of a significant decline in short interest in the month of June. As of June 30th, there was short interest totaling 331,075 shares, a decline of 44.9% from the June 15th total of 601,191 shares. Approximately 28.6% of the company’s shares are short sold. Based on an average daily volume of 387,077 shares, the days-to-cover ratio is currently 0.9 days.

PMGC Stock Up 2.8%

ELAB stock opened at $1.12 on Wednesday. The company has a debt-to-equity ratio of 0.03, a current ratio of 1.45 and a quick ratio of 1.43. The stock has a market capitalization of $1.30 million, a P/E ratio of -0.01 and a beta of -0.23. The business has a 50-day moving average of $1.54 and a 200-day moving average of $8.43. PMGC has a fifty-two week low of $1.02 and a fifty-two week high of $309.12.

PMGC (NASDAQ:ELAB) last posted its quarterly earnings data on Thursday, May 14th. The company reported ($11.22) earnings per share (EPS) for the quarter. The company had revenue of $0.68 million during the quarter.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of PMGC in a report on Friday, June 26th. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat, PMGC has a consensus rating of “Sell”.

About PMGC

Elevai Labs, Inc, a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc and changed its name to Elevai Labs, Inc in December 2021. Elevai Labs, Inc was incorporated in 2020 and is based in Newport Beach, California.